Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Genetics ; 218(4)2021 08 09.
Article in English | MEDLINE | ID: mdl-34028515

ABSTRACT

In Caenorhabditis elegans, the cha-1 gene encodes choline acetyltransferase (ChAT), the enzyme that synthesizes the neurotransmitter acetylcholine. We have analyzed a large number of cha-1 hypomorphic mutants, most of which are missense alleles. Some homozygous cha-1 mutants have approximately normal ChAT immunoreactivity; many other alleles lead to consistent reductions in synaptic immunostaining, although the residual protein appears to be stable. Regardless of protein levels, neuromuscular function of almost all mutants is temperature-sensitive, i.e., neuromuscular function is worse at 25° than at 14°. We show that the temperature effects are not related to acetylcholine release, but specifically to alterations in acetylcholine synthesis. This is not a temperature-dependent developmental phenotype, because animals raised at 20° to young adulthood and then shifted for 2 h to either 14° or 25° had swimming and pharyngeal pumping rates similar to animals grown and assayed at either 14° or 25°, respectively. We also show that the temperature-sensitive phenotypes are not limited to missense alleles; rather, they are a property of most or all severe cha-1 hypomorphs. We suggest that our data are consistent with a model of ChAT protein physically, but not covalently, associated with synaptic vesicles; and there is a temperature-dependent equilibrium between vesicle-associated and cytoplasmic (i.e., soluble) ChAT. Presumably, in severe cha-1 hypomorphs, increasing the temperature would promote dissociation of some of the mutant ChAT protein from synaptic vesicles, thus removing the site of acetylcholine synthesis (ChAT) from the site of vesicular acetylcholine transport. This, in turn, would decrease the rate and extent of vesicle-filling, thus increasing the severity of the behavioral deficits.


Subject(s)
Caenorhabditis elegans Proteins/metabolism , Choline O-Acetyltransferase/metabolism , Neuromuscular Junction/metabolism , Thermotolerance , Acetylcholine/biosynthesis , Animals , Caenorhabditis elegans , Caenorhabditis elegans Proteins/genetics , Choline O-Acetyltransferase/genetics , Cholinergic Neurons/metabolism , Mutation, Missense
2.
PLoS One ; 7(7): e40095, 2012.
Article in English | MEDLINE | ID: mdl-22808098

ABSTRACT

The recycling of synaptic vesicles requires the recovery of vesicle proteins and membrane. Members of the stonin protein family (Drosophila Stoned B, mammalian stonin 2) have been shown to link the synaptic vesicle protein synaptotagmin to the endocytic machinery. Here we characterize the unc-41 gene, which encodes the stonin ortholog in the nematode Caenorhabditis elegans. Transgenic expression of Drosophila stonedB rescues unc-41 mutant phenotypes, demonstrating that UNC-41 is a bona fide member of the stonin family. In unc-41 mutants, synaptotagmin is present in axons, but is mislocalized and diffuse. In contrast, UNC-41 is localized normally in synaptotagmin mutants, demonstrating a unidirectional relationship for localization. The phenotype of snt-1 unc-41 double mutants is stronger than snt-1 mutants, suggesting that UNC-41 may have additional, synaptotagmin-independent functions. We also show that unc-41 mutants have defects in synaptic vesicle membrane endocytosis, including a ∼50% reduction of vesicles in both acetylcholine and GABA motor neurons. These endocytic defects are similar to those observed in apm-2 mutants, which lack the µ2 subunit of the AP2 adaptor complex. However, no further reduction in synaptic vesicles was observed in unc-41 apm-2 double mutants, suggesting that UNC-41 acts in the same endocytic pathway as µ2 adaptin.


Subject(s)
Adaptor Protein Complex 2/metabolism , Adaptor Proteins, Vesicular Transport/metabolism , Caenorhabditis elegans Proteins/metabolism , Endocytosis , Synaptic Vesicles/metabolism , Adaptor Proteins, Vesicular Transport/genetics , Animals , Animals, Genetically Modified , Caenorhabditis elegans/genetics , Caenorhabditis elegans/metabolism , Caenorhabditis elegans/ultrastructure , Caenorhabditis elegans Proteins/genetics , Carrier Proteins/metabolism , Cloning, Molecular , Drosophila Proteins/metabolism , Gene Expression Regulation , Genes, Helminth/genetics , Genome/genetics , Mutation/genetics , Nerve Tissue Proteins/metabolism , Nervous System/metabolism , Phenotype , Protein Transport , Synaptic Vesicles/ultrastructure , Synaptotagmins/metabolism , Vesicular Transport Proteins
3.
Dis Model Mech ; 3(5-6): 366-76, 2010.
Article in English | MEDLINE | ID: mdl-20083577

ABSTRACT

Neuroligins are postsynaptic cell adhesion proteins that bind specifically to presynaptic membrane proteins called neurexins. Mutations in human neuroligin genes are associated with autism spectrum disorders in some families. The nematode Caenorhabditis elegans has a single neuroligin gene (nlg-1), and approximately a sixth of C. elegans neurons, including some sensory neurons, interneurons and a subset of cholinergic motor neurons, express a neuroligin transcriptional reporter. Neuroligin-deficient mutants of C. elegans are viable, and they do not appear deficient in any major motor functions. However, neuroligin mutants are defective in a subset of sensory behaviors and sensory processing, and are hypersensitive to oxidative stress and mercury compounds; the behavioral deficits are strikingly similar to traits frequently associated with autism spectrum disorders. Our results suggest a possible link between genetic defects in synapse formation or function, and sensitivity to environmental factors in the development of autism spectrum disorders.


Subject(s)
Caenorhabditis elegans/drug effects , Caenorhabditis elegans/metabolism , Cell Adhesion Molecules, Neuronal/deficiency , Mercury/toxicity , Mutation/genetics , Oxidative Stress/drug effects , Sensation/drug effects , Animals , Behavior, Animal/drug effects , Biomarkers/metabolism , Caenorhabditis elegans/cytology , Cell Adhesion Molecules, Neuronal/chemistry , Cell Adhesion Molecules, Neuronal/genetics , Cell Adhesion Molecules, Neuronal/metabolism , Cues , Genes, Reporter , Humans , Muscle Cells/cytology , Muscle Cells/drug effects , Muscle Cells/metabolism , Neurons/cytology , Neurons/drug effects , Neurons/metabolism , Protein Transport/drug effects , Recombinant Fusion Proteins/metabolism , Sequence Homology, Amino Acid , Synapses/drug effects , Synapses/metabolism , Temperature
4.
Mol Cell Neurosci ; 34(4): 642-52, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17321753

ABSTRACT

Synaptotagmin 1, encoded by the snt-1 gene in Caenorhabditis elegans, is a major synaptic vesicle protein containing two Ca(2+)-binding (C2) domains. Alternative splicing gives rise to two synaptotagmin 1 isoforms, designated SNT-1A and SNT-1B, which differ in amino acid sequence in the third, fourth, and fifth beta-strands of the second C2 domain (C2B). We report here that expression of either SNT-1 isoform under control of a strong pan-neural promoter fully rescues the snt-1 null phenotype. Furthermore, C-terminal fusions of either isoform with GFP are trafficked properly to synapses and are fully functional, unlike synaptotagmin 1Colon, two colonsGFP fusions in mice. Analysis of isoform expression with genomic GFP reporter constructs revealed that the SNT-1A and-1B isoforms are differentially expressed and localized in the C. elegans nervous system. We also report molecular, behavioral, and immunocytochemical analyses of twenty snt-1 mutations. One of these mutations, md259, specifically disrupts expression of the SNT-1A isoform and has defects in a subset of synaptotagmin 1-mediated behaviors. A second mutation, md220, is an in-frame 9-bp deletion that removes a conserved tri-peptide sequence (VIL) in the second beta-strand of the C2B domain and disrupts the proper intracellular trafficking of synaptotagmin. Site-directed mutagenesis of a functional SNT-1Colon, two colonsGFP fusion protein was used to examine the potential role of the VIL sequence in synaptotagmin trafficking. Although our results suggest the VIL sequence is most likely not a specific targeting motif, the use of SNT-1Colon, two colonsGFP fusions has great potential for investigating synaptotagmin trafficking and localization.


Subject(s)
Caenorhabditis elegans Proteins/genetics , Caenorhabditis elegans Proteins/metabolism , Central Nervous System/metabolism , Synaptotagmin I/genetics , Synaptotagmin I/metabolism , Alleles , Alternative Splicing , Amino Acid Sequence , Animals , Animals, Genetically Modified , Caenorhabditis elegans , Fluorescent Antibody Technique , Image Processing, Computer-Assisted , Microscopy, Confocal , Molecular Sequence Data , Mutagenesis, Site-Directed , Polymerase Chain Reaction , Promoter Regions, Genetic , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Transport/physiology , Recombinant Fusion Proteins
5.
Mol Biol Cell ; 17(7): 3021-30, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16641366

ABSTRACT

Sodium-dependent neurotransmitter transporters participate in the clearance and/or recycling of neurotransmitters from synaptic clefts. The snf-11 gene in Caenorhabditis elegans encodes a protein of high similarity to mammalian GABA transporters (GATs). We show here that snf-11 encodes a functional GABA transporter; SNF-11-mediated GABA transport is Na+ and Cl- dependent, has an EC50 value of 168 microM, and is blocked by the GAT1 inhibitor SKF89976A. The SNF-11 protein is expressed in seven GABAergic neurons, several additional neurons in the head and retrovesicular ganglion, and three groups of muscle cells. Therefore, all GABAergic synapses are associated with either presynaptic or postsynaptic (or both) expression of SNF-11. Although a snf-11 null mutation has no obvious effects on GABAergic behaviors, it leads to resistance to inhibitors of acetylcholinesterase. In vivo, a snf-11 null mutation blocks GABA uptake in at least a subset of GABAergic cells; in a cell culture system, all GABA uptake is abolished by the snf-11 mutation. We conclude that GABA transport activity is not essential for normal GABAergic function in C. elegans and that the localization of SNF-11 is consistent with a GABA clearance function rather than recycling.


Subject(s)
Caenorhabditis elegans Proteins/physiology , Caenorhabditis elegans/metabolism , GABA Plasma Membrane Transport Proteins/physiology , Genes, Helminth/physiology , Synapses/metabolism , gamma-Aminobutyric Acid/metabolism , Animals , Caenorhabditis elegans/chemistry , Caenorhabditis elegans Proteins/analysis , Caenorhabditis elegans Proteins/genetics , GABA Agents/pharmacology , GABA Plasma Membrane Transport Proteins/analysis , GABA Plasma Membrane Transport Proteins/genetics , Mutation , Nipecotic Acids/pharmacology , Phenotype , Phylogeny , Sodium/metabolism , Synaptic Transmission
SELECTION OF CITATIONS
SEARCH DETAIL
...